Management of patients refractory to platelet transfusion

Porselvi Chockalingam, Ronald A. Sacher

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

This article discusses the causes and management of platelet refractoriness. Improvements in the quality of platelets and leukoreduction have reduced the morbidity and mortality related to alloimmunization and refractoriness of patients to platelet transfusion. Alloimmunization can be distinguished from other causes of poor post-transfusion platelet increments by the measurement of platelet alloantibodies. Options for managing platelet refractoriness caused by alloimmunization include platelet transfusion from human leukocyte antigen-matched or donor-recipient cross-matched platelets. Prevention strategies include efforts to limit recipients' exposure to human leukocyte antigen specificities by using single-donor platelets, filtration to reduce the number of human leukocyte antigen-bearing leukocytes, and pretransfusion ultraviolet B irradiation to decrease their immunogenicity. For appropriate management of patients refractory to platelets, close cooperation and good communication are necessary between clinicians and blood centers.

Original languageEnglish
Pages (from-to)220-225
Number of pages6
JournalJournal of Infusion Nursing
Volume30
Issue number4
DOIs
Publication statusPublished - 01-07-2007
Externally publishedYes

Fingerprint

Platelet Transfusion
Blood Platelets
HLA Antigens
Tissue Donors
Isoantibodies
Quality Improvement
Leukocytes
Communication
Morbidity
Mortality

All Science Journal Classification (ASJC) codes

  • Nursing(all)

Cite this

Chockalingam, Porselvi ; Sacher, Ronald A. / Management of patients refractory to platelet transfusion. In: Journal of Infusion Nursing. 2007 ; Vol. 30, No. 4. pp. 220-225.
@article{905fcf5d9cce4b60a53c839020b51fcf,
title = "Management of patients refractory to platelet transfusion",
abstract = "This article discusses the causes and management of platelet refractoriness. Improvements in the quality of platelets and leukoreduction have reduced the morbidity and mortality related to alloimmunization and refractoriness of patients to platelet transfusion. Alloimmunization can be distinguished from other causes of poor post-transfusion platelet increments by the measurement of platelet alloantibodies. Options for managing platelet refractoriness caused by alloimmunization include platelet transfusion from human leukocyte antigen-matched or donor-recipient cross-matched platelets. Prevention strategies include efforts to limit recipients' exposure to human leukocyte antigen specificities by using single-donor platelets, filtration to reduce the number of human leukocyte antigen-bearing leukocytes, and pretransfusion ultraviolet B irradiation to decrease their immunogenicity. For appropriate management of patients refractory to platelets, close cooperation and good communication are necessary between clinicians and blood centers.",
author = "Porselvi Chockalingam and Sacher, {Ronald A.}",
year = "2007",
month = "7",
day = "1",
doi = "10.1097/01.NAN.0000281531.97183.c0",
language = "English",
volume = "30",
pages = "220--225",
journal = "Journal of Infusion Nursing",
issn = "1533-1458",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

Management of patients refractory to platelet transfusion. / Chockalingam, Porselvi; Sacher, Ronald A.

In: Journal of Infusion Nursing, Vol. 30, No. 4, 01.07.2007, p. 220-225.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Management of patients refractory to platelet transfusion

AU - Chockalingam, Porselvi

AU - Sacher, Ronald A.

PY - 2007/7/1

Y1 - 2007/7/1

N2 - This article discusses the causes and management of platelet refractoriness. Improvements in the quality of platelets and leukoreduction have reduced the morbidity and mortality related to alloimmunization and refractoriness of patients to platelet transfusion. Alloimmunization can be distinguished from other causes of poor post-transfusion platelet increments by the measurement of platelet alloantibodies. Options for managing platelet refractoriness caused by alloimmunization include platelet transfusion from human leukocyte antigen-matched or donor-recipient cross-matched platelets. Prevention strategies include efforts to limit recipients' exposure to human leukocyte antigen specificities by using single-donor platelets, filtration to reduce the number of human leukocyte antigen-bearing leukocytes, and pretransfusion ultraviolet B irradiation to decrease their immunogenicity. For appropriate management of patients refractory to platelets, close cooperation and good communication are necessary between clinicians and blood centers.

AB - This article discusses the causes and management of platelet refractoriness. Improvements in the quality of platelets and leukoreduction have reduced the morbidity and mortality related to alloimmunization and refractoriness of patients to platelet transfusion. Alloimmunization can be distinguished from other causes of poor post-transfusion platelet increments by the measurement of platelet alloantibodies. Options for managing platelet refractoriness caused by alloimmunization include platelet transfusion from human leukocyte antigen-matched or donor-recipient cross-matched platelets. Prevention strategies include efforts to limit recipients' exposure to human leukocyte antigen specificities by using single-donor platelets, filtration to reduce the number of human leukocyte antigen-bearing leukocytes, and pretransfusion ultraviolet B irradiation to decrease their immunogenicity. For appropriate management of patients refractory to platelets, close cooperation and good communication are necessary between clinicians and blood centers.

UR - http://www.scopus.com/inward/record.url?scp=34547670616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547670616&partnerID=8YFLogxK

U2 - 10.1097/01.NAN.0000281531.97183.c0

DO - 10.1097/01.NAN.0000281531.97183.c0

M3 - Review article

VL - 30

SP - 220

EP - 225

JO - Journal of Infusion Nursing

JF - Journal of Infusion Nursing

SN - 1533-1458

IS - 4

ER -